Environmental risk assessment of fluoxetine A case study with a human pharmaceutical

A. Coors (1) , K. Oakes (2) , B. Escher (3) , Kathrin Fenner (3) , Jeanne Garric (4) , M. Gust (4) , T. Knacker (1) , A. Kuester (5) , C. Kussatz (5) , P. Lopez-Mancisidor (6) , C. Metcalfe (7) , S. Monteiro (8) , T. Moon (9) , J. Parrott (10) , Alexandre R.R. Pery (11) , M. Ramil (12) , P. Sanchez Arguello (6) , M. Servos (2) , T.A. Ternes (12) , V. Trudeau (9) , G. van Der Kraak (13)

1 Eokotoxikologie GmbH
2 University of Waterloo [Waterloo]
3 Swiss Federal Institute of Aquatic Science and Technology
4 UR BELY - Biologie des écosystèmes aquatiques
5 UBA - German Federal Environmental Agency / Umweltbundesamt
6 INIA
7 Trent University of Ottawa
8 Central Science Laboratory
9 University of Ottawa [Ottawa]
10 ECCC - Environment and Climate Change Canada
11 INERIS - Institut National de l'Environnement Industriel et des Risques
12 Bundesanstalt fur Gewasserkunde
13 University of Guelph

Domaines: Toxicologie; Sciences de l'environnement

A. Coors, K. Oakes, B. Escher, Kathrin Fenner, Jeanne Garric, et al.. Environmental risk assessment of fluoxetine A case study with a human pharmaceutical. 18. SETAC Europe Annual Meeting, May 2008, Varsovie, Poland. ⟨ineris-00970351⟩